Sonoma Pharmaceuticals (SNOA) Operating Expenses (2010 - 2025)

Sonoma Pharmaceuticals' Operating Expenses history runs 16 years deep, the most recent figure standing at $2.3 million for Q4 2025.

• In Q4 2025, Operating Expenses rose 1.17% year-over-year to $2.3 million; the TTM figure through Dec 2025 stood at $9.5 million (changed 0.39% YoY), while the FY2025 annual figure was $9.2 million, down 2.87% from the prior year.
• Operating Expenses was $2.3 million for Q4 2025 at Sonoma Pharmaceuticals, down from $2.5 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $3.2 million in Q1 2022 to a low of $2.0 million in Q1 2023.
• Historically, Operating Expenses has averaged $2.4 million across 5 years, with a median of $2.3 million in 2021.
• The sharpest annual moves came in 2021 and 2024: Operating Expenses slumped 46.28% in 2021, then climbed 24.32% in 2024.
• A 5-year view of Operating Expenses shows it stood at $2.2 million in 2021, then climbed by 23.32% to $2.7 million in 2022, then fell by 13.55% to $2.3 million in 2023, then declined by 0.13% to $2.3 million in 2024, then increased by 1.17% to $2.3 million in 2025.
• The last three Operating Expenses figures came in at $2.3 million (Q4 2025), $2.5 million (Q3 2025), and $2.6 million (Q2 2025), per Business Quant data.